AI early warning system for cancer spread
Part of Cancer clinical trials.
This study uses artificial intelligence to analyze your imaging scans and medical information to predict whether your cancer might spread to distant parts of your body. The goal is to catch potential spread earlier so doctors can intervene sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with cancer confirmed by a tissue biopsy
- Your cancer has not spread to distant parts of your body at the time you join
- You have scheduled follow-up imaging scans as part of your regular cancer care
- Your medical records and baseline test results are complete and available
- You agree to let researchers use your imaging scans and medical data for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
Hear when a new Malignant Tumor With Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.